![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
The Pros and Cons of the "Buy and Bill" Model
Leaders chime in on the benefits of the "buy and bill" model.
By
Date
January 26, 2022
By: MedSurg Editorial Team
Read time: 5 minutes
An alternative to the traditional "buy and bill" model of pharmaceutical distribution is bagging, which removes the financial burden from the provider because the specialty pharmacy or third-party payer must purchase the drug before it arrives in the provider's office. McKesson health systems leaders, Barbara Giacomelli and Valerie Russo provide insight on the benefits of the "buy and bill" model, and how to determine what's appropriate for your business.
Related Stories
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
In a unique, retreat-style setting, health systems leaders had close conversations around best practices, wins, struggles, and solutions.
Discover three key takeaways from a recent C-suite roundtable discussing the benefits and challenges of central fill for health systems.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
The top three Prescribed Perspectives articles downloaded by health systems in May.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.
As the infusion services market continues to evolve and challenge one of health systems’ longstanding service lines – new opportunities are also emerging.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
The top three Prescribed Perspectives articles downloaded by health systems in March.